Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Norwegian Platform for Production of Antiviral Chicken Egg Yolk Immunoglobulins for Viral Pandemics Preparedness

Version 1 : Received: 27 June 2022 / Approved: 30 June 2022 / Online: 30 June 2022 (03:37:45 CEST)

How to cite: Ravlo, E.; Evensen, L.; Sanson, G.; Ianevski, A.; Skjervold, P.O.; Kainov, D.; Bjørås, M. Norwegian Platform for Production of Antiviral Chicken Egg Yolk Immunoglobulins for Viral Pandemics Preparedness . Preprints 2022, 2022060411 (doi: 10.20944/preprints202206.0411.v1). Ravlo, E.; Evensen, L.; Sanson, G.; Ianevski, A.; Skjervold, P.O.; Kainov, D.; Bjørås, M. Norwegian Platform for Production of Antiviral Chicken Egg Yolk Immunoglobulins for Viral Pandemics Preparedness . Preprints 2022, 2022060411 (doi: 10.20944/preprints202206.0411.v1).

Abstract

Background: Some viruses cause outbreaks which require immediate attention. Neutralizing antibodies could be developed for viral outbreak management. However, development of monoclonal antibodies is often long, laborious, and unprofitable. Here we report a Norwegian platform for development of chicken polyclonal neutralizing antibodies with powerful therapeutic potential. Methods: Layers were immunized twice with 14-day interval using purified RBD of SARS-CoV-2. Eggs were harvested 14 days after the second immunization. Polyclonal IgY antibodies were extracted. Binding of anti-RBD IgY to RBD was measured by indirect ELISA. Neutralization capacity of anti-RBD IgYs was measured in Vero-E6 cells infected with SARS-CoV-2-mCherry strain using fluorescence and cell viability assay. In addition, the effect of IgYs on the expression of SARS-CoV-2 and host cytokine genes in lungs of Syrian Golden hamsters was examined using qRT-PCR. Results: Anti-RBD IgYs efficiently bind RBD of S protein of SARS-CoV-2 in situ, neutralize the virus in vitro, and lower viral RNA amplification without significant alteration of virus-mediated immune gene expression in vivo. Conclusions: Altogether, our results indicated that chicken polyclonal IgYs can be attractive targets for pre-clinical and clinical development for rapid management of outbreaks of emerging and re-emerging viruses.

Keywords

IgY; SARS-CoV-2; Vero-E6, Syrian Golden hamster; antiviral strategy

Subject

LIFE SCIENCES, Virology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.

We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.